Paola Savoia
Brescia, 25123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer.
Journal: Neurobiology of disease
Published: January 23, 2019
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease.
Journal: Experimental neurology
Published: December 12, 2016
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 13, 2016
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons.
Journal: Molecular neurobiology
Published: July 04, 2016
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: October 22, 2015
The D3 dopamine receptor: From structural interactions to function.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 20, 2014
Receptor heteromers in Parkinson's disease and L-DOPA-induced dyskinesia.
Journal: CNS & neurological disorders drug targets
Published: November 13, 2012
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in l-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease.
Journal: Neurobiology of disease
Published: August 08, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026